Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 8/20 | 0.53 |
| ▸ | NAALAD2 | Q9Y3Q0 | 3/20 | 0.53 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.53 |
| ▸ | GGH | Q92820 | 1/20 | 0.50 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL910799 | 1.00 | FOLH1 (0.53) | FOLH1NAALAD2RIMKLAGGHNOD1 | |
| SCHEMBL910946 | 1.00 | FOLH1 (0.53) | FOLH1NAALAD2RIMKLAGGHNOD1 | |
| SCHEMBL3649431 | 0.89 | NOD1 (0.56) | FOLH1NAALAD2RIMKLAGGHNOD1 | |
| SCHEMBL1300787 | 0.89 | NOD1 (0.46) | FOLH1NOD1 | |
| SCHEMBL8324059 | 0.89 | NOD1 (0.56) | FOLH1NAALAD2RIMKLAGGHNOD1 | |
| SCHEMBL8768068 | 0.87 | FOLH1 (0.61) | FOLH1NAALAD2RIMKLAGGHCYP1A2 | |
| SCHEMBL8769194 | 0.87 | FOLH1 (0.61) | FOLH1NAALAD2RIMKLAGGHCYP1A2 | |
| SCHEMBL29356795 | 0.87 | FOLH1 (0.61) | FOLH1NAALAD2RIMKLAGGHCYP1A2 | |
| SCHEMBL141783 | 0.87 | FOLH1 (0.61) | FOLH1NAALAD2RIMKLAGGHCYP1A2 | |
| Hydrochloric Acid SCHEMBL15530021 | 0.87 | NOD1 (0.55) | FOLH1NAALAD2RIMKLAGGHNOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746912-A1 | ORGANIC CYTOTOXIN OLIGOMERS AND USES THEREOF AS A PAYLOAD IN ANTIBODY-DRUG CONJUGATES | Simris Biologics GmbH (DE) | 2026-05-27 | — | — | EP | disclosed |
| WO-2025021727-A1 | ORGANIC CYTOTOXIN OLIGOMERS AND USES THEREOF AS A PAYLOAD IN ANTIBODY-DRUG CONJUGATES | SIMRIS BIOLOGICS GMBH (DE) | 2025-01-30 | — | — | WO | disclosed |
| EP-4494656-A1 | ORGANIC CYTOTOXIN OLIGOMERS AND USES THEREOF AS A PAYLOAD IN ANTIBODY-DRUG CONJUGATES | Simris Biologics GmbH (DE) | 2025-01-22 | — | — | EP | disclosed |
| CN-116148340-A | Gold nano-particle array with strong stability and reusability and preparation and application thereof | 汕头大学 | 2023-05-23 | — | — | CN | disclosed |
| US-20110004019-A1 | Parakeratosis Inhibitor, Pore-Shrinking Agent, Or Rough Skin Inhibiting/Ameliorating Agent, And External Composition For Skin Containing The Same | SHISEIDO COMPANY LTD. (JP) | 2011-01-06 | — | — | US | disclosed |
| EP-2255780-A1 | PARAKERATOSIS INHIBITOR, PORE SHRINKING AGENT OR AGENT FOR PREVENTING OR IMPROVING ROUGH SKIN, AND COMPOSITION FOR EXTERNAL USE ON THE SKIN CONTAINING THE SAME | Shiseido Company, Ltd. (JP) | 2010-12-01 | — | — | EP | disclosed |
| US-20080188079-A1 | METAL-POLISHING COMPOSITION AND CHEMICAL MECHANICAL POLISHING METHOD BY USING THE SAME | FUJIFILM CORPORATION (JP) | 2008-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110004019-A1 | Parakeratosis Inhibitor, Pore-Shrinking Agent, Or Rough Skin Inhibiting/Ameliorating Agent, And External Composition For Skin Containing The Same | CUTA, GLRA3, ARGLU1 | FOLH1 4099/4885NAALAD2 1692/4885RIMKLA 881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.